Pre-made Miromavimab benchmark antibody ( Whole mAb (Mouse), anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-348

Pre-Made Miromavimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-348-1mg 1mg 3090
GMP-Bios-ab-348-10mg 10mg Inquiry
GMP-Bios-ab-348-100mg 100mg Inquiry
GMP-Bios-ab-348-xmg ＞100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Miromavimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody
INN Name Miromavimab
TargetRabies Virus Strain ERA GP Ectodomain Epitope G-II
FormatWhole mAb (Mouse)
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusNFD
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2019
Year Recommended2020
CompaniesCandila Healthcare
Conditions ApprovedRabies
Conditions Activena
Conditions Discontinuedna
Development Techna